Bridge to Life

Private

#Organ Transplant #Transplant Preservation #Machine Perfusion

A medical device company specializing in organ preservation and transplant solutions, including machine perfusion technology for kidney, liver, and other organ transplants.

Company Info

Sector:Medical Devices / Transplant

Headquarters:Columbus, Ohio, USA

Founded:2004

Website:bridgetolife.com/

Upcoming Milestones & Key Dates

2026-Q4

Commercial

UK NICE NHS funding implementation

2027

Pipeline

Additional organ perfusion platform expansion

Clinical Development Pipeline

LifePort Kidney Transporter

Target: Hypothermic machine perfusion

Kidney transplant preservation

Preclinical

Phase 1

Phase 2

Phase 3

Approved

LifePort Liver Transporter

Target: Hypothermic machine perfusion

Liver transplant preservation

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Belzer UW Solution

Target: Cold storage solution

Organ preservation

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Recent News

Clinical Regulatory•Aug 27, 2026•PR Newswire FDA

UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life's VitaSmart™ Hypothermic Oxygenated Perfusion System ↗

The UK National Institute for Health and Care Excellence (NICE) has issued guidance recommending routine NHS funding for Bridge to Life's VitaSmart hypothermic oxygenated perfusion system for organ transplant preservation.

Bridge to Life

Company Info

Upcoming Milestones & Key Dates

Clinical Development Pipeline

LifePort Kidney Transporter

LifePort Liver Transporter

Belzer UW Solution

Recent News

UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life's VitaSmart™ Hypothermic Oxygenated Perfusion System ↗

Leadership Team

Don Webber

Bill Soto

Dave Kravitz

Careers & Job Openings

See all open roles